Atlas Trials

Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study

Clinical trial NCT05199038 · UNKNOWN

Trial details

NCT number
NCT05199038
Sponsor
Tanta University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Esophageal Varices
Start date
2022-06-01
Primary completion
2023-06-01
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.